Literature DB >> 27891768

Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.

Karn Wijarnpreecha1, Panadeekarn Panjawatanan2, Natasorn Lekuthai3, Charat Thongprayoon1, Wisit Cheungpasitporn4, Patompong Ungprasert3,4.   

Abstract

BACKGROUND: The association between hyperuricaemia and nonalcoholic fatty liver disease (NAFLD), one of the leading causes of cirrhosis worldwide, has been demonstrated in recent epidemiological studies. This meta-analysis was conducted to summarize all available data and to estimate the risk of NAFLD among subjects with hyperuricaemia.
METHODS: Comprehensive literature review was conducted using MEDLINE and EMBASE database through August 2016 to identify studies that compared the risk of NAFLD among subjects with hyperuricaemia vs those with normal uric acid level. Effect estimates from individual study were extracted and combined together using random-effect, generic inverse variance method of DerSimonian and Laird.
RESULTS: Twenty-five studies met the eligibility criteria and were included in the meta-analysis. The risk of NAFLD in subjects with hyperuricaemia was significantly higher than subjects with normal uric acid level with the pooled odds ratio (OR) of 1.97 (95% confidence interval (CI), 1.69-2.29). The heterogeneity between studies of the overall analysis was high with an I2 of 87%. Subgroup analysis based on 11 studies that provided data on males subgroup and nine studies that provided data on females subgroup showed that the risk was significantly increased for both sexes with pooled OR of 1.64 (95% CI, 1.40-1.93) among males and pooled OR of 2.21 (95% CI, 1.85-2.64) among females.
CONCLUSIONS: A significantly increased risk of NAFLD among patients with hyperuricaemia was demonstrated in this meta-analysis. Further studies are required to establish the role of uric acid in the pathogenesis of NAFLD.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hyperuricaemia; meta-analysis; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis

Mesh:

Substances:

Year:  2016        PMID: 27891768     DOI: 10.1111/liv.13329

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  15 in total

1.  Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Karn Wijarnpreecha; Panadeekarn Panjawatanan; Paul T Kroner; Wisit Cheungpasitporn; Patompong Ungprasert
Journal:  Ann Gastroenterol       Date:  2020-09-16

2.  Elevated triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio increased risk of hyperuricemia: a 4-year cohort study in China.

Authors:  Xin-Yao Liu; Qiao-Yu Wu; Zhi-Heng Chen; Guang-Yu Yan; Yao Lu; Hai-Jiang Dai; Ying Li; Ping-Ting Yang; Hong Yuan
Journal:  Endocrine       Date:  2020-01-15       Impact factor: 3.633

Review 3.  Association between gastroesophageal reflux disease and nonalcoholic fatty liver disease: A meta-analysis.

Authors:  Karn Wijarnpreecha; Panadeekarn Panjawatanan; Charat Thongprayoon; Veeravich Jaruvongvanich; Patompong Ungprasert
Journal:  Saudi J Gastroenterol       Date:  2017 Nov-Dec       Impact factor: 2.485

4.  Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population.

Authors:  Xinting Pan; Xiaoxu Xie; Hewei Peng; Xiaoling Cai; Huiquan Li; Qizhu Hong; Yunli Wu; Xu Lin; Shanghua Xu; Xian-E Peng
Journal:  Front Public Health       Date:  2020-07-02

5.  The correlation between controlled attenuation parameter and metabolic syndrome and its components in middle-aged and elderly nonalcoholic fatty liver disease patients.

Authors:  Yue-Yan Hu; Ning-Ling Dong; Qiu Qu; Xu-Fan Zhao; Hong-Ju Yang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

6.  Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.

Authors:  Chao Yang; Shujuan Yang; Weiwei Xu; Junhui Zhang; Wenguang Fu; Chunhong Feng
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

Review 7.  Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis.

Authors:  Karn Wijarnpreecha; Panadeekarn Panjawatanan; Charat Thongprayoon; Veeravich Jaruvongvanich; Patompong Ungprasert
Journal:  Saudi J Gastroenterol       Date:  2018 Jan-Feb       Impact factor: 2.485

8.  Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study.

Authors:  Chao Yang; Shujuan Yang; Chunhong Feng; Chuan Zhang; Weiwei Xu; Liyun Zhang; Yixin Yan; Jiaqi Deng; Okugbe Ebiotubo Ohore; Jing Li
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

Review 9.  NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome.

Authors:  Valerio Rosato; Mario Masarone; Marcello Dallio; Alessandro Federico; Andrea Aglitti; Marcello Persico
Journal:  Int J Environ Res Public Health       Date:  2019-09-14       Impact factor: 3.390

10.  Changing trajectories of serum uric acid and risk of non-alcoholic fatty liver disease: a prospective cohort study.

Authors:  Zhimin Ma; Chaonan Xu; Xiaoping Kang; Shan Zhang; Haibin Li; Lixin Tao; Deqiang Zheng; Xiuhua Guo; Xinghua Yang
Journal:  J Transl Med       Date:  2020-03-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.